Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kurt M. Eichler currently holds 549,273 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kurt M. Eichler has been a net buyer of SBPH stock. They have purchased $1.7M and sold $50.4K worth of shares.
Kurt M. Eichler's most recent insider trade was on Dec 30, 2019, when they sold 40,000 shares at $1.26 per share.
Kurt M. Eichler serves as Executive at Spring Bank Pharmaceuticals, Inc. (SBPH). They have executed 36 insider transactions totaling $1.8M over their tenure at the company.
Kurt M. Eichler holds the position of Executive at Spring Bank Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Kurt M. Eichler has shown a buying trading pattern, with $1.7M in total purchases and $50.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kurt M. Eichler was on Jun 27, 2017, when they purchased $1000.0K worth of SBPH shares. This transaction involved 76,923 shares at $13.00 per share.
Kurt M. Eichler currently owns 549,273 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kurt M. Eichler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kurt M. Eichler has 36 Form 4 filings on record as an insider at Spring Bank Pharmaceuticals, Inc..
Set alerts for Kurt M. Eichler and 40,000+ other insiders.